Bioventus Inc. logo

Bioventus Inc.

BVS | undefined
Chart Builder DCF Calculator
$13.45
+$0.07 (+0.52%)
Sep 22, 2026, 9:35 AM ET · Market open

Market Data

Market Cap
$901.73M
Enterprise Value
$1.14B
Beta
0.65
Average Volume
697.41K
Shares Outstanding (Diluted)
70.84M
Shares Change YoY
3.36%
Institutional Ownership
75.87%
Exchange
NASDAQ
ISIN
US09075A1088

Price Performance

Price Change 1M
-8.0%
Price Change 3M
43.3%
Price Change 6M
45.3%
Price Change YTD
84.6%
Price Change 1Y
91.8%
Price Change 3Y
354.3%
Price Change 5Y
-9.2%
1M CAGR (ann.)
-5.8%
1Y CAGR (ann.)
84.9%
5Y CAGR (ann.)
-1.6%
All-Time CAGR
-6.3%

Valuation

PE Ratio
17.29
Forward PE
14.22
PEG Ratio
0.00
Forward PEG
0.91
PS Ratio
1.55
Forward PS
1.40
PB Ratio
3.95
P/FCF Ratio
8.78
P/Adj. FCF Ratio
10.68
P/OCF Ratio
9.31
EV/Sales
1.95
EV/EBIT
19.41
EV/EBITDA
12.24
EV/FCF
11.07
Earnings Yield
5.8%
FCF Yield
11.4%
Adj. FCF Yield
9.4%

Financial Health

Net Debt
$219M
Total Debt
$263.75M
Cash & Short-Term Investments
$29.46M
Total Assets
$673.35M
Current Ratio
1.69
Quick Ratio
1.17
Debt / Equity Ratio
1.16
Debt / EBITDA
2.84
Debt / FCF
2.57
OCF / Debt
0.40
Interest Coverage
3.11
Altman Z-Score
2.08
Piotroski F-Score
8

Margins & Profitability

Gross Profit Margin
68.0%
Operating Profit Margin
10.6%
EBITDA Margin
15.9%
Net Profit Margin
9.4%
FCF Margin
17.6%
Adj. FCF Margin
14.5%
SBC / Revenue
2.6%
SBC Impact (per share)
-17.7%

Returns

Return on Assets
8.1%
Return on Equity
28.4%
Return on Invested Capital
11.4%
Return on Capital Employed
11.9%
Return on Tangible Assets
17.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
4.5%
Revenue CAGR 5Y
9.1%
Revenue CAGR 10Y
8.4%
EPS CAGR 3Y
2204.1%
EPS CAGR 5Y
1.4%
EPS CAGR 10Y
-19.7%
FCF CAGR 3Y
135.9%
FCF CAGR 5Y
34.5%
FCF CAGR 10Y
13.8%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
7
EPS Growth Next 3Y
10.9%
Revenue Growth Next 3Y
8.3%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
$0.17
EPS Growth Est (next Q)
13.3%
Revenue Est (next Q)
$149.51M
Revenue Growth Est (next Q)
7.8%

Fair Value Estimates

Graham Number
$8.42
Graham Upside
-36.7%
Lynch Fair Value
$3.85
Lynch Upside
-71.1%
Price Target
$18.33
Price Target Upside
37.7%

Cash Flow

Operating Cash Flow
$105.81M
Free Cash Flow
$102.65M
Adj. Free Cash Flow
$84.46M
FCF Per Share
$1.39
OCF Per Share
$1.43
OCF/S Ratio
16.6%

Income Statement

Revenue
$581.85M
Gross Profit
$395.64M
Operating Income
$61.83M
EBITDA
$92.82M
Net Income
$54.46M
EPS (Diluted)
$0.77
Revenue / Employee
$612.47K
Profit / Employee
$57.33K
Employees
950

© 2026 bestshares.com. All rights reserved.